NEW YORK (GenomeWeb News) – Scientists from drug-discovery company Therasis and Columbia University have identified a pair of genes that, when simultaneously activated, cause the most lethal form of glioblastoma.

The findings help validate Therasis' bioinformatics and systems biology approach to reconstructing maps of regulatory networks in specific cancer cell types, which could lead to the discovery of new biomarkers and therapeutic targets, a company official said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.